What antihypertensive medication is appropriate for a patient with Addison's disease (primary adrenal insufficiency) who has hypoglycemia and severe hypertension (blood pressure 180/115 mm Hg) with a pulse of 90 beats/min?

Immediate Management of Hypertension in Addison's Disease with Hypoglycemia

First address the hypoglycemia emergently with IV dextrose and stress-dose hydrocortisone (100 mg IV), then reduce or discontinue fludrocortisone to treat the hypertension, and if blood pressure remains elevated after optimizing glucocorticoid replacement, use an ACE inhibitor or angiotensin II receptor blocker as first-line antihypertensive therapy. 1

Critical First Steps: Address the Acute Crisis

• Treat hypoglycemia immediately with IV dextrose and administer stress-dose hydrocortisone (100 mg IV bolus) as this patient may be in or approaching adrenal crisis despite the paradoxical hypertension 2, 3
• Hypoglycemia in Addison's disease reflects inadequate cortisol for counter-regulatory glucose homeostasis and represents a medical emergency that can be fatal if untreated 3
• The combination of hypoglycemia with severe hypertension in Addison's disease strongly suggests excessive mineralocorticoid replacement (fludrocortisone overdosing) as the cause of hypertension 1, 4

Optimize Glucocorticoid Replacement First

• Review and potentially reduce glucocorticoid dosing if the patient is receiving more than 15-25 mg hydrocortisone daily (or equivalent), as excessive glucocorticoid replacement can cause hypertension 5, 1
• Hydrocortisone itself has potent mineralocorticoid activity that may contribute to hypertension, particularly at higher doses 5
• Once the acute hypoglycemia resolves, reassess the maintenance glucocorticoid regimen to ensure it is not excessive 1

Address Mineralocorticoid Excess

• Reduce or temporarily discontinue fludrocortisone as the primary intervention for hypertension in Addison's disease, since BP 180/115 with normal pulse suggests volume overload from mineralocorticoid excess 1, 4
• Look for clinical and biochemical signs of mineralocorticoid excess: hypertension, suppressed plasma renin activity (PRA), hypokalemia, and edema 4
• Standard fludrocortisone dosing is 0.05-0.2 mg daily; in hypertensive patients, dose reduction is recommended while monitoring for hyperkalemia 4
• Measure plasma renin activity (PRA) to guide fludrocortisone adjustment—the goal is upper normal range PRA, not suppressed levels 1, 4

Antihypertensive Medication Selection

First-Line Agent

• Use an ACE inhibitor or angiotensin II receptor blocker (ARB) if blood pressure remains elevated after optimizing steroid replacement and reducing fludrocortisone 1
• These agents are particularly appropriate when PRA is toward the upper end of normal or elevated, and fludrocortisone should remain unchanged in this scenario 1
• ACE inhibitors/ARBs address the renin-angiotensin-aldosterone axis dysfunction that can occur even in treated Addison's disease 1

Second-Line Agent

• Dihydropyridine calcium channel blockers (e.g., amlodipine, nifedipine) are clinically useful as second-line agents if additional blood pressure control is needed 1

Agents to AVOID

• Never use aldosterone antagonists (spironolactone, eplerenone) in Addison's disease—these will worsen adrenal insufficiency and precipitate crisis 1
• Avoid diuretics (thiazides, loop diuretics) in hypertensive Addison's disease without heart failure, as they can cause dangerous volume depletion and electrolyte disturbances in patients already at risk 1
• Do not use amiloride or triamterene (ENaC blockers) unless Liddle syndrome is confirmed, which would present with suppressed renin AND aldosterone—not the case in Addison's disease 6

Common Pitfalls to Avoid

• Do not assume hypertension rules out adrenal crisis—the hypoglycemia indicates inadequate glucocorticoid effect despite the elevated blood pressure 2, 3
• Do not start standard antihypertensives before optimizing steroid replacement—the hypertension may resolve with fludrocortisone reduction alone 1, 4
• Do not continue full-dose fludrocortisone while adding antihypertensives—this treats the symptom rather than the cause 1
• Recognize that current replacement regimens are often associated with mild hypovolemia when properly dosed, so aggressive diuresis can be dangerous 4

Monitoring Strategy

• Recheck blood pressure, electrolytes (sodium, potassium), and PRA after adjusting fludrocortisone dose 4
• Aim for PRA in the upper normal range, not suppressed levels that indicate mineralocorticoid excess 1, 4
• Monitor for signs of inadequate mineralocorticoid replacement after dose reduction: postural hypotension, weakness, salt craving, hyperkalemia, hyponatremia 4
• Ensure patient education on stress dosing and sick-day rules to prevent future adrenal crises 2